NHS to pilot 'potentially revolutionary' cancer blood test

Developed by GRAIL

Adam Saville
clock • 2 min read

The 'Galleri blood test' aims to detect cancers early by looking for abnormal DNA

The NHS is to trial a ‘potentially revolutionary' blood test that could discover a range of different cancer types is to be trialled by the NHS, the national health service's chief executive Sir Simon Stevens has announced. Known as the Galleri blood test, it has been developed by the company GRAIL to spot early signs of cancer by seeking out abnormal DNA shed from cells into the blood. DNA from cancer cells often have differences in the chemical tags compared to DNA from healthy cells. The test has so far only been trialled on people with cancer symptoms, however the NHS England pilo...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

First Health joins amii
PMI

First Health joins amii

New intermediary member

Cameron Roberts
clock 28 August 2025 • 1 min read
Unum UK director joins amii executive committee
PMI

Unum UK director joins amii executive committee

Paula Coffey joins

Cameron Roberts
clock 18 August 2025 • 1 min read
Circle Health Group promotes Paul Manning to CEO
PMI

Circle Health Group promotes Paul Manning to CEO

Focus on expanding the group’s hospital network

Jaskeet Briah
clock 17 July 2025 • 1 min read